pharma · Renal Transplantation · Rheumatoid Arthritis (RA)
Astellas Pharma
Astellas Pharma Inc
Astellas Pharma is a pharma organization headquartered in CN. Primary therapeutic focus areas include Renal Transplantation, Rheumatoid Arthritis (RA), Non-small Cell Lung Cancer, Restless Legs Syndrome, Hot Flashes. Nov
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP HQ
12,378 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP
- Employees
- 12,378
- Programs
- 20
- Drugs
- 12
- Patents
- 25
Gilteritinib
Phase 2 · small molecule · Non-Small-Cell Lung Cancer
Gilteritinib for Non-Small-Cell Lung Cancer is a Phase 2 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Internal code 2215-CL-5101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Astellas Pharma Inc
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Non-Small-Cell Lung Cancer
- Status
- terminated
- Trials
- 1